Relmada Therapeutics, Inc. has grown revenue 54% a year over three years and 287% a year over five. Revenue growth, 3-year annual rate: +54% (Biotechnology median +17%). Revenue growth, 5-year rate: +287%, growth has slowed since the five-year average. Years of annual history on file: 19, FY2004 to FY2025, as filed.

RLMDRelmada Therapeutics, Inc.

Healthcare

$3.16+59% 1Y

$3.16

$1.9352 weeks$7.86

Is it growing?

Is RLMD growing?

Relmada Therapeutics, Inc. has grown revenue 54% a year over three years and 287% a year over five.

+54%

Revenue growth, 3-year annual rate · Biotechnology median +17% · compounding fast · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: +287%
Revenue growth, 5-year rate · +54% over three · growth has slowed since the five-year average
Years of annual history on file: 19
Years of annual history on file · FY2004 to FY2025, as filed

Details›